THE LARGEST PROFITABLE CHAIN OF PSYCHEDELICS CLINICS IN THE U.S. WITH 13 LOCATIONS ACROSS NINE STATES AND 15 MORE IN THE NEXT 18 MONTHS. $9,000,000 + REVENUE RUN RATE & EBITDA POSITIVE

The Delic Umbrella Of Related Businesses Create A Self-Sustaining Ecosystem That Will Drive Clinics Growth

Sponsored
Message: VIDEO: Delic Patient Letters Tell Powerful Stories Of Ketamine On Their Mental Health & Survival

To understand Delic Holdings $DELC $DELCF you first must understand that Psychedelics are going to go through a parabolic, paradigm shifting growth cycle in the next 5 years because of their ability to treat anxiety, depression & other mental illnesses - which have proven to be far superior to traditional pharmaceuticals.  Just look at these numbers:

Response to Ketamine Treatment of Depressive Disorders:

  • 80+ % Effective with Bipolar and Depression
  • 76+ % Effective with Major Depressive Disorders
  • 65+ % Effective with Depression with PTSD and Anxiety
  • 50+ %  Effective with Borderline Personality Disorder

Compare these to 63% of Americans who have used Rx drugs to treat anxiety, depression and PTSD but say they still have symptoms.

As incredible as these results are, both $DELC and Psychedelics couldn’t be coming along at a better time given the fact that Mental Health problems are getting exponentially worse after COVID, with 51.5M people in the U.S. having experienced a mental health condition

ENTER DELIC

$DELC is the largest profitable chain of psychedelics clinics in the United States with 13 locations across 9 states - and 15 more locations coming in the next 18 months

How big is Delic?  The Company’s Ketamine Wellness Centers will serve more patients than any other ketamine therapy provider this year.  Other highlights include:

  • $9m+ Revenue Run Rate & EBITDA Positive
  • 2021 increase net assets to $10M+ from $2.1M in 2020
  • Well capitalized to grow organically and via M&A as industry grows

 

GROWTH EXPECTED TO REACH HUNDREDS OF CLINICS

$DELC Co-Founder and Executive Chairman, Matt Stang isn’t resting on the Company’s leadership laurels and has set his sights on hundreds of clinics in the coming 5 years thanks to:

  • Consumer Acceptance - The Public Is Fully Embracing Psychedelics
  • Friendly Legislation -  Legalization Of MDMA & Psilocybin Treatments Is Coming
  • Insurance Coverage - The Insurance Industry Is Increasingly Covering Psychedelics Treatments

To this end, Stang points to the Company’s most recent announcements as support for his growth target:

Ketamine Wellness Centers (KWC) Expands Insurance Coverage with Medicare for Ketamine Therapy Patients

Ketamine Wellness Centers (KWC) Partners with Veterans Administration Community Care Network (VA-CCN) To Expand SPRAVATO(TM) Coverage

If you believe in the future of psychedelics and want to know more about both the overall industry and Delic itself, then sit back and watch this great interview with CEO, Kevin Nicholson

 

 

Share
New Message
Please login to post a reply